Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Revenue: 2017-2025

Historic Revenue for Crinetics Pharmaceuticals (CRNX) over the last 6 years, with Sep 2025 value amounting to $143,000.

  • Crinetics Pharmaceuticals' Revenue was N/A to $143,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is 74.11% down from last year.
  • According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Revenue is $143,000, which was down 86.13% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Crinetics Pharmaceuticals' Revenue ranged from a high of $3.1 million in Q1 2022 and a low of $143,000 during Q3 2025.
  • Its 3-year average for Revenue is $823,375, with a median of $519,500 in 2024.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 76.11% in 2024, then skyrocketed by 158.40% in 2025.
  • Over the past 4 years, Crinetics Pharmaceuticals' Revenue (Quarterly) stood at $709,000 in 2022, then fell by 24.45% to $346,000 in 2023, then plummeted by 59.62% to $399,000 in 2024, then skyrocketed by 158.40% to $143,000 in 2025.
  • Its Revenue stands at $143,000 for Q3 2025, versus $1.0 million for Q2 2025 and $361,000 for Q1 2025.